Major factors driving growth of Clinical Trial Management System market include increasing partnerships between biopharma companies and CROs, rising number of ongoing clinical trials, rising government funding & grants to support clinical trials, availability of advanced CTMS solutions, and growing customer base for CTMS solutions.
The global Clinical Trial Management System market is projected to reach USD 1,065.6 million by 2022 from USD 590 million in 2017, at a CAGR of 12.6%. On basis of component, CTMS market is segmented into software and services.
Software segment is expected to have largest share of market
Download Sample Brochure of Clinical Trial Management System Market spread across 216 Pages, Profiling 12 Companies and Supported with 34 Tables and 48 Figures is now available at www.rnrmarketresearch.com/contact…name=58723 .
Clinical trial management system market players include Medidata Solutions, Inc.
(U.S.), PAREXEL International Corporation (U.S.), BioClinica Inc. (U.S.), Bio-Optronics, Inc. (U.S.), ERT (U.S.), eClinforce (U.S.), Merge Healthcare Incorporated (U.S.), DATATRAK International Inc.
(U.S.), Veeva Systems, Inc. (U.S.), DSG Inc. (U.S.), Forte Research Systems, Inc.
(U.S.), and MedNet Solutions, Inc. (U.S.), among others.
2 Clinical Trial Management Systems Market Share Analysis, By Key Players (2016)
3 Competitive Scenario and Trends
4 Product Launches and Enhancements (2014–2017)
5 Agreements, Partnerships, and Collaborations (2014–2017)
6 Market Expansions (2014–2017)
7 Mergers and Acquisitions (2014–2017)
Report at www.rnrmarketresearch.com/contacts/=58723 .
In Clinical Trial Management System Market the Asia-Pacific region has become an attractive destination for companies offering Clinical Trial Management System. High growth in this regional segment can be attributed to a number of factors, like rising number of clinical trials, presence of a large number of CROs, government initiatives, increase in outsourcing of clinical trials, availability of large & diverse patient population.
Stakeholders of Clinical Trial Management System Market are as follows:
- Healthcare IT service providers
- eClinical solution vendors
- Clinical research organizations
- Pharmaceutical/biopharmaceutical companies
- Research and development (R&D) companies
- Business research and consulting service providers
- Medical research laboratories
- Academic medical centers/universities/hospitals
Clinical Trial Management System Market further segmented into enterprise Clinical Trial Management System Market and site CTMS on basis of type. Enterprise CTMS segment is expected to command largest share of global CTMS market in 2016, and is expected to grow at the highest CAGR in forecast period.
This is attributed to the widespread adoption of enterprise CTMS by majority of end users.
1 Clinical Trial Management Systems Market: Overview (2017–2022)
2 Global Clinical Trial Management System Market, By Component, 2017 vs 2022
3 Global Clinical Trial Managements System Market, By Type, 2017 vs 2022
4 Global Clinical Trial Management System Market, By End-User and Mode of Delivery (2017)
5 Clinical Trial Management System Market By Country, 2017
Contract research organizations segment estimated to witness highest growth rate in Clinical Trial Management System Market, by end user. Geographically, North America expected to command largest share of global CTMS market in 2016, followed by Europe.
Large share of North American market primarily driven by rising number of ongoing clinical trials, rising government support for conducting clinical trials, and presence of a large customer base.
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.